Associate Sponsors

Co-sponsor

Bliss GVS Pharma reports consolidated net loss of Rs 50.11 crore in the December 2021 quarter

Image
Capital Market
Last Updated : Jan 31 2022 | 9:05 AM IST

Sales rise 31.82% to Rs 216.26 crore

Net loss of Bliss GVS Pharma reported to Rs 50.11 crore in the quarter ended December 2021 as against net profit of Rs 25.55 crore during the previous quarter ended December 2020. Sales rose 31.82% to Rs 216.26 crore in the quarter ended December 2021 as against Rs 164.06 crore during the previous quarter ended December 2020. ParticularsQuarter EndedDec. 2021Dec. 2020% Var.Sales216.26164.06 32 OPM %15.8023.33 -PBDT39.1641.45 -6 PBT34.7337.09 -6 NP-50.1125.55 PL

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Jan 31 2022 | 8:09 AM IST

Next Story